301293 Stock Overview
Operates a network of hospitals that provide medical services.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 301293 from our risk checks.
Sanbo Hospital Management Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥41.40 |
| 52 Week High | CN¥60.60 |
| 52 Week Low | CN¥29.61 |
| Beta | 0 |
| 11 Month Change | 26.45% |
| 3 Month Change | 7.09% |
| 1 Year Change | -18.34% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -46.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301293 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 34.4% | 34.5% | 26.5% |
| 1Y | -18.3% | -14.7% | 1.2% |
Return vs Industry: 301293 exceeded the CN Healthcare industry which returned -23.8% over the past year.
Return vs Market: 301293 underperformed the CN Market which returned -7.9% over the past year.
Price Volatility
| 301293 volatility | |
|---|---|
| 301293 Average Weekly Movement | 6.7% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 4.5% |
Stable Share Price: 301293's share price has been volatile over the past 3 months.
Volatility Over Time: 301293's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 1,954 | n/a | www.sbnkjt.com |
Sanbo Hospital Management Group Limited operates a network of hospitals that provide medical services. The company was founded in 2003 and is based in Beijing, China.
Sanbo Hospital Management Group Limited Fundamentals Summary
| 301293 fundamental statistics | |
|---|---|
| Market cap | CN¥8.53b |
| Earnings (TTM) | CN¥101.31m |
| Revenue (TTM) | CN¥1.38b |
84.2x
P/E Ratio6.2x
P/S RatioIs 301293 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301293 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.38b |
| Cost of Revenue | CN¥1.06b |
| Gross Profit | CN¥318.59m |
| Other Expenses | CN¥217.28m |
| Earnings | CN¥101.31m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 26, 2024
| Earnings per share (EPS) | 0.49 |
| Gross Margin | 23.14% |
| Net Profit Margin | 7.36% |
| Debt/Equity Ratio | 0% |
How did 301293 perform over the long term?
See historical performance and comparison